Glucocorticoids in T cell apoptosis and function

Cellular and Molecular Life Sciences

Volumn 63, Issue 1, 2006, Pages 60-72

  Herold, M J ^a   McPherson, K G ^a   Reichardt, H M ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Apoptosis; Bcl 2 family; Caspase; Gene targeting; Glucocorticoid; T cell development; Transgenesis

Indexed keywords

CASPASE; CELL NUCLEUS RECEPTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; PROTEIN BCL 2; STEROID HORMONE;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CELL FUNCTION; CELL SPECIFICITY; CELL TYPE; HOMEOSTASIS; HORMONE ACTION; IMMUNOMODULATION; LYMPHOCYTE FUNCTION; NONHUMAN; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; GLUCOCORTICOIDS; HUMANS; RECEPTORS, GLUCOCORTICOID; T-LYMPHOCYTES; THYMUS GLAND;

EID: 30744460611     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-005-5390-y     Document Type: Review

References (131)

1. Bommhardt U., Beyer M., Hünig T. and Reichardt H. M. (2004) Molecular and cellular mechanisms of T cell development. Cell. Mol. Life Sci. 61: 263-280
2. Bevan M. J. (1997) In thymic selection, peptide diversity gives and takes away. Immunity 7: 175-178
3. Budd R. C. (2001) Activation-induced cell death. Curr. Opin. Immunol. 13: 356-362
4. Opferman J. T. and Korsmeyer S. J. (2003) Apoptosis in the development and maintenance of the immune system. Nat. Immunol. 4: 410-415
5. Tuckermann J. P., Kleiman A., McPherson K. G. and Reichardt H. M. (2005) Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit. Rev. Clin. Lab. Sci. 42: 71-104
6. Wyllie A. H. (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556
7. Beato M., Herrlich P. and Schütz G. (1995) Steroid hormone receptors: many actors in search of a plot. Cell 83: 851-857
8. Reichardt H. M., Kaestner K. H., Tuckermann J., Kretz O., Wessely O., Bock R. et al. (1998) DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93: 531-541
9. Distelhorst C. W. (2002) Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ. 9: 6-19
10. Frankfurt O. and Rosen S. T. (2004) Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates. Curr. Opin. Oncol. 16: 553-563
11. Vacchio M. S. and Ashwell J. D. (2000) Glucocorticoids and thymocyte development. Semin. Immunol. 12: 475-485
12. Baumann S., Dostert A., Novac N., Bauer A., Schmid W., Fas S. C. et al. (2005) Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer. Blood 106: 617-625
13. Brewer J. A., Kanagawa O., Sleckman B. P. and Muglia L. J. (2002) Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo. J. Immunol. 169: 1837-1843
14. Ploner C., Schmidt S., Presul E., Renner K., Schrocksnadel K., Rainer J. et al. (2005) Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia. J. Steroid Biochem. Mol. Biol. 93: 153-160
15. Reichardt H. M. (2004) Immunomodulatory activities of glucocorticoids: insights from transgenesis and gene targeting. Curr. Pharm. Des. 10: 2797-2805
16. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K. et al. (1995) The nuclear receptor superfamily: the second decade. Cell 83: 835-839
17. Pratt W. B., Gehring U. and Toft D. O. (1996) Molecular chaperoning of steroid hormone receptors. EXS 11: 79-95
18. Luisi B. F., Xu W. X., Otwinowski Z., Freedman L. P., Yamamoto K. R. and Sigler P. B. (1991) Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352: 497-505
19. Jenkins B. D., Pullen C. B. and Darimont B. D. (2001) Novel glucocorticoid receptor coactivator effector mechanisms. Trends Endocrinol. Metab. 12: 122-126
20. Gascoyne D. M., Kypta R. M. and Vivanco M. M. (2003) Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xL. J. Biol. Chem. 278: 18022-18029
21. Deroo B. J. and Archer T. K. (2001) Glucocorticoid receptor activation of the I kappa B alpha promoter within chromatin. Mol. Biol. Cell. 12: 3365-3374
22. D'Adamio F., Zollo O., Moraca R., Ayroldi E., Bruscoli S., Bartoli A. et al. (1997) A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 7: 803-812
23. Nocentini G., Giunchi L., Ronchetti S., Krausz L. T. Bartoli A., Moraca R. et al. (1997) A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc. Natl. Acad. Sci. USA 94: 6216-6221
24. Schmid E., Schmid W., Jantzen M., Mayer D., Jastorff B. and Schutz G. (1987) Transcription activation of the tyrosine aminotransferase gene by glucocorticoids and cAMP in primary hepatocytes. Eur. J. Biochem. 165: 499-506
25. Hanson R. W. and Reshef L. (1997) Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu. Rev. Biochem. 66: 581-611
26. Heck S., Bender K., Kullmann M., Gottlicher M., Herrlich P. and Cato A. C. (1997) I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor. EMBO J. 16: 4698-4707
27. Heck S., Kullmann M., Gast A., Ponta H., Rahmsdorf H. J., Herrlich P. et al. (1994) A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J. 13: 4087-4095
28. Vacca A., Felli M. P., Farina A. R., Martinotti S., Maroder M., Screpanti I. et al. (1992) Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J. Exp. Med. 175: 637-646
29. Imai E., Miner J. N., Mitchell J. A., Yamamoto K. R. and Granner D. K. (1993) Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J. Biol. Chem. 268: 5353-5356
30. Stoecklin E., Wissler M., Moriggl R. and Groner B. (1997) Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription. Mol. Cell. Biol. 17: 6708-6716
31. Tuckermann J. P., Reichardt H. M., Arribas R., Richter K. H., Schutz G. and Angel P. (1999) The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin. J. Cell. Biol. 147: 1365-1370
32. Reichardt H. M., Horsch K., Gröne H. J., Kolbus A., Beug H., Hynes N. et al. (2001) Mammary gland development and lactation are controlled by different glucocorticoid receptor activities. Eur. J. Endocrinol. 145: 519-527
33. Reichardt H. M., Tuckermann J. P., Göttlicher M., Vujic M., Weih F., Angel P. et al. (2001) Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J. 20: 7168-7173.
34. Tronche F., Opherk C., Moriggl R., Kellendonk C., Reimann A., Schwake L. et al. (2004) Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth. Genes Dev. 18: 492-497
35. Limbourg F. P., Huang Z., Plumier J. C., Simoncini T., Fujioka M., Tuckermann J. et al. (2002) Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J. Clin. Invest. 110: 1729-1738
36. Lu N. Z. and Cidlowski J. A. (2005) Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol. Cell 18: 331-342
37. Diba F., Watson C. S. and Gametchu B. (2001) 5′UTR sequences of the glucocorticoid receptor 1A transcript encode a peptide associated with translational regulation of the glucocorticoid receptor. J. Cell. Biochem. 81: 149-161
38. Purton J. F., Monk J. A., Liddicoat D. R., Kyparissoudis K., Sakkal S., Richardson S. J. et al. (2004) Expression of the glucocorticoid receptor from the IA promoter correlates with T lymphocyte sensitivity to glucocorticoid- induced cell death. J. Immunol. 173: 3816-3824
39. Zhou J. and Cidlowski J. A. (2005) The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids 70: 407-417
40. Yeager M. P., Guyre P. M. and Munck A. U. (2004) Glucocorticoid regulation of the inflammatory response to injury. Acta Anaesthesiol. Scand. 48: 799-813
41. Hench P. S., Kendall E. C., Slocumb C. H. and Policy H. F. (1950) Effects of cortisone acetate and pituitray ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Arch. Intern. Med. 85: 545-566
42. Webster J. I., Tonelli L. and Sternberg E. M. (2002) Neuroendocrine regulation of immunity. Annu. Rev. Immunol. 20: 125-163
43. Balsalobre A., Brown S. A., Marcacci L., Tronche F., Kellendonk C., Reichardt H. M. et al. (2000) Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science 289: 2344-2347
44. King L. B., Vacchio M. S., Dixon K., Hunziker R., Margulies D. H. and Ashwell J. D. (1995) A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development. Immunity 3: 647-656
45. Pazirandeh A., Xue Y., Prestegaard T., Jondal M. and Okret S. (2002) Effects of altered glucocorticoid sensitivity in the T cell lineage on thymocyte and T cell homeostasis. FASEB J. 16: 727-729
46. Cole T. J., Blendy J. A., Monaghan A. P., Krieglstein K., Schmid W., Aguzzi A. et al. (1995) Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 9: 1608-1621
47. Purton J. F., Boyd R. L., Cole T. J. and Godfrey D. I. (2000) Intrathymic T cell development and selection proceeds normally in the absence of glucocorticoid receptor signaling. Immunity 13: 179-186
48. Purton J. F., Zhan Y., Liddicoat D. R., Hardy C. L., Lew A. M., Cole T. J. et al. (2002) Glucocorticoid receptor deficient thymic and peripheral T cells develop normally in adult mice. Eur. J. Immunol. 32: 3546-3555
49. Brewer J. A., Khor B., Vogt S. K., Muglia L. M., Fujiwara H., Haegele K. E. et al. (2003) T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation. Nat. Med. 9: 1318-1322
50. Reichardt H. M., Umland T., Bauer A., Kretz O. and Schütz G. (2000) Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock. Mol. Cell. Biol. 20: 9009-9017
51. Pazirandeh A., Jondal M. and Okret S. (2005) Conditional expression of a glucocorticoid receptor transgene in thymocytes reveals a role for thymic-derived glucocorticoids in thymopoiesis in vivo. Endocrinology 146: 2501-2507
52. Hengartner M. O. (2000) The biochemistry of apoptosis. Nature 407: 770-776
53. Strasser A. (2005) The role of BH3-only proteins in the immune system. Nat. Rev. Immunol. 5: 189-200
54. Wang X. (2001) The expanding role of mitochondria in apoptosis. Genes Dev. 15: 2922-2933
55. Cheng E. H., Wei M. C., Weiler S., Flavell R. A., Mak T. W., Lindsten T. et al. (2001) BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell 8: 705-711
56. Green D. R. and Kroemer G. (2004) The pathophysiology of mitochondrial cell death. Science 305: 626-629
57. Zong W. X., Edelstein L. C., Chen C., Bash J. and Gelinas C. (1999) The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev. 13: 382-387
58. Kaufmann T., Schlipf S., Sanz J., Neubert K., Stein R. and Borner C. (2003) Characterization of the signal that directs Bcl-x(L), but not Bcl-2, to the mitochondrial outer membrane. J. Cell. Biol. 160: 53-64
59. Bassik M. C., Scorrano L., Oakes S. A., Pozzan T. and Korsmeyer S. J. (2004) Phosphorylation of BCL-2 regulates ER Ca(2+) homeostasis and apoptosis. EMBO J. 23: 1207-1216
60. Herrant M., Jacquel A., Marchetti S., Belhacene N., Colosetti P., Luciano F. et al. (2004) Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis. Oncogene 23: 7863-7873
61. Barnhart B. C., Alappat E. C. and Peter M. E. (2003) The CD95 type I/type II model. Semin. Immunol. 15: 185-193
62. Chipuk J. E. and Green D. R. (2005) Do inducers of apoptosis trigger caspase-independent cell death? Nat. Rev. Mol. Cell Biol. 6: 268-275
63. Kroemer G. and Martin S. J. (2005) Caspase-independent cell death. Nat. Med. 11: 725-730
64. Michallet M. C., Saltel F., Preville X., Flacher M., Revillard J. P. and Genestier L. (2003) Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion. Blood 102: 3719-3726
65. Bidere N., Lorenzo H. K., Carmona S., Laforge M., Harper F., Dumont C. et al. (2003) Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J. Biol. Chem. 278: 31401-31411
66. Canbay A., Guicciardi M. E., Higuchi H., Feldstein A., Bronk S. F., Rydzewski R. et al. (2003) Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J. Clin. Invest. 112: 152-159
67. Cuervo A. M. (2004) Autophagy: many paths to the same end. Mol. Cell. Biochem. 263: 55-72
68. Liu N., Phillips T., Zhang M., Wang Y. Opferman J. T., Shah R. et al. (2004) Serine protease inhibitor 2A is a protective factor for memory T cell development. Nat. Immunol. 5: 919-926
69. Forsthoefel A. M. and Thompson E. A. (1987) Glucocorticoid regulation of transcription of the c-myc cellular protooncogene in P1798 cells. Mol. Endocrinol. 1: 899-907
70. Tosa N., Murakami M., Jia W. Y., Yokoyama M., Masunaga T., Iwabuchi C. et al. (2003) Critical function of T cell death-associated gene 8 in glucocorticoid-induced thymocyte apoptosis. Int. Immunol. 15: 741-749
71. Malone M. H., Wang Z. and Distelhorst C. W. (2004) The glucocorticoid-induced gene tdag8 encodes a pro-apoptotic G protein-coupled receptor whose activation promotes glucocorticoid-induced apoptosis. J. Biol. Chem. 279: 52850-52859
72. Wang Z., Malone M. H., Thomenius M. J., Zhong F., Xu F. and Distelhorst C. W. (2003) Dexamethasone-induced gene 2 (dig2) is a novel pro-survival stress gene induced rapidly by diverse apoptotic signals. J. Biol. Chem. 278: 27053-27058
73. Wang Z., Malone M. H., He H., McColl K. S. and Distelhorst C. W. (2003) Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis. J. Biol. Chem. 278: 23861-23867
74. Abrams M. T., Robertson N. M., Yoon K. and Wickstrom E. (2004) Inhibition of glucocorticoid-induced apoptosis by targeting the major splice variants of BIM mRNA with small interfering RNA and short hairpin RNA. J. Biol. Chem. 279: 55809-55817
75. Han J., Flemington C., Houghton A. B., Gu Z., Zambetti G. P., Lutz R. J. et al. (2001) Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc. Natl. Acad. Sci. USA 98: 11318-11323
76. Tonko M., Ausserlechner M. J., Bernhard D., Helmberg A. and Kofler R. (2001) Gene expression profiles of proliferating vs. G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid-induced apoptosis. FASEB J. 15: 693-699
77. Medh R. D., Webb M. S., Miller A. L., Johnson B. H., Fofanov Y., Li T. et al. (2003) Gene expression profile of human lymphoid CEM cells sensitive and resistant to glucocorticoid-evoked apoptosis. Genomics 81: 543-555
78. Bouillet P., Metcalf D., Huang D. C., Tarlinton D. M., Kay T. W., Kontgen F. et al. (1999) Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286: 1735-1738
79. Marsden V. S., O'Connor L., O'Reilly L. A., Silke J., Metcalf D., Ekert P. G. et al. (2002) Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 419: 634-637
80. Memon S. A., Moreno M. B., Petrak D. and Zacharchuk C. M. (1995) Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma. J. Immunol. 155: 4644-4652
81. Huang S. T. and Cidlowski J. A. (2002) Phosphorylation status modulates Bcl-2 function during glucocorticoid-induced apoptosis in T lymphocytes. FASEB J. 16: 825-832
82. Mann C. L., Hughes F. M. Jr and Cidlowski J. A. (2000) Delineation of the signaling pathways involved in glucocorticoid-induced and spontaneous apoptosis of rat thymocytes. Endocrinology 141: 528-538
83. Susin S. A., Lorenzo H. K., Zamzami N., Marzo I., Snow B. E., Brothers G. M. et al. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446
84. Veis D. J., Sorenson C. M., Shutter J. R. and Korsmeyer S. J. (1993) Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75: 229-240
85. Hsu Y. T., Wolter K. G. and Youle R. J. (1997) Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc. Natl. Acad. Sci. USA 94: 3668-3672
86. Jia L., Macey M. G., Yin Y. Newland A. C. and Kelsey S. M. (1999) Subcellular distribution and redistribution of Bcl-2 family proteins in human leukemia cells undergoing apoptosis. Blood 93: 2353-2359
87. Brandt J. van den, Wang D. and Reichardt H. M. (2004) Resistance of single-positive thymocytes to glucocorticoid-induced apoptosis is mediated by CD28 signaling. Mol. Endocrinol. 18: 687-695
88. Motoyama N., Wang F., Roth K. A., Sawa H., Nakayama K., Negishi I. et al. (1995) Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267: 1506-1510
89. Lindsten T., Ross A. J., King A., Zong W. X., Rathmell J. C., Shiels H. A. et al. (2000) The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell 6: 1389-1399
90. Wei M. C., Zong W. X., Cheng E. H., Lindsten T., Panoutsakopoulou V., Ross A. J. et al. (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730
91. Zong W. X., Lindsten T., Ross A. J., MacGregor G. R. and Thompson C. B. (2001) BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15: 1481-1486
92. Rathmell J. C., Lindsten T., Zong W. X., Cinalli R. M. and Thompson C. B. (2002) Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat. Immunol. 3: 932-939
93. Marsden V. S. and Strasser A. (2003) Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu. Rev. Immunol. 21: 71-105
94. Yin X. M. (2000) Bid, a critical mediator for apoptosis induced by the activation of Fas/TNF-R1 death receptors in hepatocytes. J. Mol. Med. 78: 203-211
95. Yin X. M., Wang K., Gross A., Zhao Y., Zinkel S., Klocke B. et al. (1999) Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400: 886-891
96. Mok C. L., Gil-Gomez G., Williams O., Coles M., Taga S., Tolaini M. et al. (1999) Bad can act as a key regulator of T cell apoptosis and T cell development. J. Exp. Med. 189: 575-586
97. Datta S. R., Ranger A. M., Lin M. Z., Sturgill J. F., Ma Y. C., Cowan C. W. et al. (2002) Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis. Dev. Cell 3: 631-643
98. Ranger A. M., Zha J., Harada H., Datta S. R., Danial N. N., Gilmore A. P. et al. (2003) Bad-deficient mice develop diffuse large B cell lymphoma. Proc. Natl. Acad. Sci. USA 100: 9324-9329
99. Jeffers J. R., Parganas E., Lee Y. Yang C., Wang J., Brennan J. et al. (2003) Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4: 321-328
100. Villunger A., Michalak E. M., Coultas L., Mullauer F., Bock G., Ausserlechner M. J. et al. (2003) p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302: 1036-1038
101. Talanian R. V., Quinlan C., Trautz S., Hackett M. C., Mankovich J. A., Banach D. et al. (1997) Substrate specificities of caspase family proteases. J. Biol. Chem. 272: 9677-9682
102. Hughes F. M. Jr and Cidlowski J. A. (1998) Glucocorticoid-induced thymocyte apoptosis: protease-dependent activation of cell shrinkage and DNA degradation. J. Steroid Biochem. Mol. Biol. 65: 207-217
103. Marchetti M. C., Di Marco B., Cifone G., Migliorati G. and Riccardi C. (2003) Dexamethasone-induced apoptosis of thymocytes: role of glucocorticoid receptor-associated Src kinase and caspase-8 activation. Blood 101: 585-593
104. Li P., Allen H., Banerjee S. and Seshadri T. (1997) Characterization of mice deficient in interleukin-1 beta converting enzyme. J. Cell. Biochem. 64: 27-32
105. O'Reilly L. A., Ekert P., Harvey N., Marsden V., Cullen L., Vaux D. L. et al. (2002) Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9. Cell Death Differ. 9: 832-841
106. Salmena L., Lemmers B., Hakem A., Matysiak-Zablocki E., Murakami K., Au P. Y. et al. (2003) Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 17: 883-895
107. Kuida K., Haydar T. F., Kuan C. Y., Gu Y., Taya C., Karasuyama H. et al. (1998) Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94: 325-337
108. Yoshida H., Kong Y. Y., Yoshida R., Elia A. J., Hakem A., Hakem R. et al. (1998) Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94: 739-750
109. Kuida K., Zheng T. S., Na S., Kuan C., Yang D., Karasuyama H. et al. (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384: 368-372
110. Tonomura N., McLaughlin K., Grimm L., Goldsby R. A. and Osborne B. A. (2003) Glucocorticoid-induced apoptosis of thymocytes: requirement of proteasome-dependent mitochondrial activity. J. Immunol. 170: 2469-2478
111. Yang Y., Fang S., Jensen J. P., Weissman A. M. and Ashwell J. D. (2000) Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288: 874-877
112. Reth M. (2002) Hydrogen peroxide as second messenger in lymphocyte activation. Nat. Immunol. 3: 1129-1134
113. Cifone M. G., Migliorati G., Parroni R., Marchetti C., Millimaggi D., Santoni A. et al. (1999) Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. Blood 93: 2282-2296
114. Bortner C. D., Hughes F. M. Jr and Cidlowski J. A. (1997) A primary role for K+ and Na+ efflux in the activation of apoptosis. J. Biol. Chem. 272: 32436-32442
115. Jayaraman T. and Marks A. R. (1997) T cells deficient in inositol 1,4,5-trisphosphate receptor are resistant to apoptosis. Mol. Cell. Biol. 17: 3005-3012
116. Göttlicher M., Heck S. and Herrlich P. (1998) Transcriptional cross-talk, the second mode of steroid hormone receptor action. J. Mol. Med. 76: 480-489
117. Screpanti I., Morrone S., Meco D., Santoni A., Gulino A., Paolini R. et al. (1989) Steroid sensitivity of thymocyte subpopulations during intrathymic differentiation: effects of 17 beta-estradiol and dexamethasone on subsets expressing T cell antigen receptor or IL-2 receptor. J. Immunol. 142: 3378-3383
118. Tacke M., Clark G. J., Dallman M. J. and Hünig T. (1995) Cellular distribution and costimulatory function of rat CD28: regulated expression during thymocyte maturation and induction of cyclosporin A sensitivity of costimulated T cell responses by phorbol ester. J. Immunol. 154: 5121-5127
119. Reiser H. and Schneeberger E. E. (1994) The costimulatory molecule B7 is expressed in the medullary region of the murine thymus. Immunology 81: 532-537
120. Gratiot-Deans J., Ding L., Turka L. A. and Nunez G. (1993) bcl-2 proto-oncogene expression during human T cell development: evidence for biphasic regulation. J. Immunol. 151: 83-91
121. Veis D. J., Sentman C. L., Bach E. A. and Korsmeyer S. J. (1993) Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J. Immunol. 151: 2546-2554
122. Grillot D. A., Merino R. and Nunez G. (1995) Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J. Exp. Med. 182: 1973-1983
123. Tolosa E., King L. B. and Ashwell J. D. (1998) Thymocyte glucocorticoid resistance alters positive selection and inhibits autoimmunity and lymphoproliferative disease in MRL-lpr/lpr mice. Immunity 8: 67-76
124. Lu F. W., Yasutomo K., Goodman G. B., McHeyzer-Williams L. J., McHeyzer-Williams M. G., Germain R. N. et al. (2000) Thymocyte resistance to glucocorticoids leads to antigen-specific unresponsiveness due to holes in the T cell repertoire. Immunity 12: 183-192
125. Jondal M., Pazirandeh A. and Okret S. (2004) Different roles for glucocorticoids in thymocyte homeostasis? Trends Immunol. 25: 595-600
126. Vacchio M. S., Papadopoulos V. and Ashwell J. D. (1994) Steroid production in the thymus: implications for thymocyte selection. J. Exp. Med. 179: 1835-1846
127. Pazirandeh A., Xue Y., Rafter I., Sjovall J., Jondal M. and Okret S. (1999) Paracrine glucocorticoid activity produced by mouse thymic epithelial cells. FASEB J. 13: 893-901
128. Lechner O., Wiegers G. J., Oliveira-Dos-Santos A. J., Dietrich H., Recheis H., Waterman M. et al. (2000) Glucocorticoid production in the murine thymus. Eur. J. Immunol. 30: 337-346
129. Hollenberg S. M., Weinberger C., Ong E. S., Cerelli G., Oro A., Lebo R. et al. (1985) Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318: 635-641
130. Stephens G. L., Ashwell J. D. and Ignatowicz L. (2003) Mutually antagonistic signals regulate selection of the T cell repertoire. Int. Immunol. 15: 623-632
131. Finotto S., Krieglstein K., Schober A., Deimling F., Lindner K., Bruhl B. et al. (1999) Analysis of mice carrying targeted mutations of the glucocorticoid receptor gene argues against an essential role of glucocorticoid signalling for generating adrenal chromaffin cells. Development 126: 2935-2944